|
PUS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37369999997361E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.0809000000076E-06 |
| Normal-vs-Stage2 |
6.161600E-03 |
| Normal-vs-Stage3 |
4.844700E-04 |
| Normal-vs-Stage4 |
3.328000E-01 |
| Stage1-vs-Stage2 |
4.411800E-01 |
| Stage1-vs-Stage3 |
9.075800E-01 |
| Stage1-vs-Stage4 |
7.136300E-02 |
| Stage2-vs-Stage3 |
5.083400E-01 |
| Stage2-vs-Stage4 |
3.337400E-01 |
| Stage3-vs-Stage4 |
1.470350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.28329999971433E-07 |
| Normal-vs-AfricanAmerican |
4.647400E-04 |
| Normal-vs-Asian |
1.908230E-01 |
| Caucasian-vs-AfricanAmerican |
1.900410E-01 |
| Caucasian-vs-Asian |
2.716800E-01 |
| AfricanAmerican-vs-Asian |
5.906000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75400000079762E-08 |
| Normal-vs-Female |
4.196000E-03 |
| Male-vs-Female |
2.897800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.795700E-04 |
| Normal-vs-Extreme_Weight |
7.58050000548849E-08 |
| Normal-vs-Obese |
6.814100E-04 |
| Normal-vs-Extreme_Obese |
5.643000E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.679400E-01 |
| Normal_Weight-vs-Obese |
6.351800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.176600E-01 |
| Extreme_Weight-vs-Obese |
8.276400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.039200E-01 |
| Obese-vs-Extreme_Obese |
6.123400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.746200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.554700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.83739998163668E-09 |
| Normal-vs-Age(81-100Yrs) |
1.166850E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.372030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.605100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.343920E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.536800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.130200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.734400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.6538999987078E-08 |
| Normal-VS-Type2 PRCC |
1.51555999999831E-05 |
| Normal-VS-KIRP CIMP |
2.208600E-01 |
| Normal-VS-Unclassified PRCC |
1.639800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.214200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.496400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.156400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.786770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.418200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.505200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58558999999725E-05 |
| Normal-vs-N1 |
2.438000E-01 |
| Normal-vs-N2 |
1.762330E-03 |
| N0-vs-N1 |
1.501880E-02 |
| N0-vs-N2 |
4.965400E-01 |
| N1-vs-N2 |
1.011210E-01 |
|
|
